Collectively, our findings indicate that FHL2, as a positive regulator of NPY and MCP-1, is closely linked to the mechanism of obesity-associated lipid accumulation and inflammation in VAT. Here, FHL2 is linked to obesity due to melanocortin 4 receptor deficiency.